Havas hires Langland vet to helm latest trial recruiter, Faze
U.K.-based Havas Lynx Faze aims to take a decidedly people-focused approach to patient recruitment.
Most recent articles by Marc Iskowitz
Publicis decision to divest pharma contract sales unit was not client-driven: source
After the network shared plans to shed its contract commercial organization, some speculated the move may have been client-specific. The network refutes that rationale.
An open letter to healthcare marketers about the MM&M Awards
As we introduce new categories, the standard for winning an MM&M Award remains. It’s why I’m calling on the entire community to submit better awards entries.
Why healthcare agencies must redefine their role in philanthropic work
Agencies that view philanthropy merely as pro-bono work shortchange their people and are missing a chance to bring private-sector creativity to public health needs.
Women’s salary slide should be a wake-up call
Shrinking the gender pay gap in life sci marketing will take a concerted effort.
An all-new version of mmm-online.com just launched
It’s faster, friendlier, and more flexible. Read all about the online enhancements here.
Transparency may have taken a back seat on this diversity drive
MM&M/Publicis Health’s first Diversity Survey reveals some notable shifts to making the healthcare industry more inclusive, yet many agencies didn’t feel like opening up about their diversity numbers.
How drugmakers are facing the entrance of consumer giants into healthcare
As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.
Agencies enable staff to find well-being through work
Anatomy of Agency Culture is a supplement designed not only to showcase internal programs, but to examine them with an eye on how they impact company culture.
Data-driven. Obsessive. A little pushy. Meet this year’s Top 40 Healthcare Transformers
Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.
